IPO Boutique Research, Color & More Information for Subscribers
This past week two IPOs debuted Here’s a look at the up-to-date active IPO pipeline. Following the holiday week, the IPO market was relatively subdued. The up-coming week, we will see a return to an active market as a total six IPOs and four follow-on offerings are on the schedule. IPO Schedule – Week of 7/17[…]
The biggest headline from the IPO market this week came from a company who has not “officially” filed for its initial public offering with the SEC. Roku Inc., the maker of devices and software for streaming services, wants to go public by the end of 2017 according to the Wall Street Journal. The journal states[…]
The brief hiatus in the IPO market for the July 4th holiday is now over. Four companies launched their respective IPOs on Monday morning — all with a trade date of July 20th. While the official pipeline is not overloaded in terms of quantity, we continue to hear from our sources that “deals are coming”.[…]
This past week zero IPOs debuted, zero updated terms and one new deals were filed. Here’s a look at the up-to-date active IPO pipeline. With the fourth of July holiday falling on a Tuesday, the syndicate market was extremely quiet with zero IPOs coming to market and just two follow-on offerings. The upcoming week will mostly[…]
SUBSCRIBE TO IPOBoutique’s Free Weekly Newsletter It was a third consecutive strong month for IPO activity as June 17 companies come to market, however, the success of these deals were a mixed bag. Six of the 17 IPOs in the month opened below the offering price and a trio of deals had to severely cut[…]
IPO Investors show discipline in pricing with Blue Apron HIGHLIGHTS Correction won’t be because of IPO market IPO investors dictated Blue Apron price Unicorn valuations are being kept in check “Down-Rounds” to go public are likely The IPO market ended the month of June with a jolt. Eight new companies went public. Many had mixed[…]
IPO Boutique keeps apprised of the active pipeline. Currently there are 57 active IPOs in the pipeline as of July 7, 2017. No SPACs or Unit Offerings are included. NEW FILINGS Company: Sienna Biopharmaceuticals, Inc. Symbol: SNNA Description: They are a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and[…]
This past week eight IPOs debuted marking one of the busiest IPO weeks of 2017 thus far. Biotech deals had a very mixed week and other new issues showed price sensitivity in an extremely busy week for the IPO market. The best deal this week, Dova Pharmaceuticals (Nasdaq: DOVA), upsized its offering 10% and[…]
IPO Boutique keeps apprised of the active pipeline. Currently there are 56 active IPOs in the pipeline as of June 30, 2016. No SPACs or Unit Offerings are included. TERMS ADDED Company: RBB Bancorp Symbol: TBD Description: RBB Bancorp adopted a strategic plan focused on providing commercial banking services to first generation immigrants, initially concentrating[…]
Company: Akcea Therapeutics, Inc. Symbol: AKCA Description: They are a late-stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. Shares: 9.62 million Price Range: $12.00-$14.00 Trade Date: 6/30 Underwriter(s): Cowen and Company, Stifel, Wells Fargo Securities Co-Manager: BMO Capital Markets Link to S-1/A Prospectus[…]
Company: Aileron Therapeutics, Inc. Symbol: ALRN Description: They are a clinical-stage biopharmaceutical company that is focused on developing and commercializing a novel class of therapeutics called stapled peptides. Shares: 3.75 million Price Range: $15.00-$17.00 Trade Date: 6/29 Underwriter(s): BofA Merrill Lynch, Jefferies Co-Manager: William Blair, Canaccord Genuity Link to S-1/A Prospectus Investor Access: This deal[…]
Company: Byline Bancorp, Inc. Symbol: BY Description: They are a bank holding company headquartered in Chicago, Illinois and conduct all their business activities through their subsidiary, Byline Bank, a full service commercial bank. Shares: 5.7 million Price Range: $19.00-$21.00 Trade Date: 6/29 Underwriter(s): BofA Merrill Lynch, Keefe Bruyette & Woods Co-Manager: Piper Jaffray, Sandler O’Neill[…]
Company: Tintri, Inc. Symbol: TNTR Description Their highly-differentiated and extensible enterprise cloud platform combines cloud management software, web services and a range of all-flash storage systems. Shares: 8.7 million Price Range: $10.50-$12.50 Trade Date: 6/29 Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Pacific Crest Securities Co-Manager: Needham & Company, Piper Jaffray, Raymond James, William Blair Link[…]
Company: Dova Pharmaceuticals, Inc. Symbol: DOVA Description: They are a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases that are treated by specialist physicians, with an initial focus on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Shares: 4.1 million Price Range: $15.00-$17.00 Trade Date: 6/29 Underwriter(s): J.P.[…]
Company: Blue Apron Holdings, Inc. Symbol: APRN Description: Blue Apron was founded in 2012 premised on a simple desire our founders wanted to cook at home with their families, but they found grocery shopping and menu planning burdensome, time consuming, and expensive. Shares: 30 million Price Range: $15.00-$17.00 Trade Date: 6/29 Underwriter(s): Goldman Sachs &[…]
Company: Mersana Therapeutics, Inc. Symbol: MRSN Description They are a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need. Shares: 5 million Price Range: $14.00-$16.00 Trade Date: 6/28 Underwriter(s): J.P. Morgan, Cowen and Company, Leerink Partners Co-Manager: Wedbush PacGrow[…]
Company: Esquire Financial Holdings, Inc. Symbol: ESQ Description: They are a bank holding company headquartered in Jericho, New York and registered under the Bank Holding Company Act of 1956, as amended (the “BHC Act”). Shares: 2.5 million Price Range: $14.00-$16.00 Trade Date: 6/27 Underwriter(s): Sandler O’ Neill + Partners Link to S-1/A Prospectus Investor Access:[…]
Four IPOs came to market including a strong debut from the second largest cash raise to debut in 2017. Altice USA (NYSE: ATUS) upsized its offering 37% and raised $1.91bn with a slightly above mid-range $30.00 pricing. ‘ATUS’ opened with a first trade of $31.60, or 5.3% above the offering price, and rallied in its[…]
SIGN UP FOR IPO BOUTIQUE’S FREE NEWSLETTER There are ten IPOs on the schedule for this week including five healthcare offerings. Below is the IPO schedule for the upcoming week: Tuesday – 6/27 Avenue Therapeutics (Nasdaq: ATXI) is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl,[…]
New Filings & Updated Terms (Week ending 6.23.17) IPO Boutique keeps apprised of the active pipeline. Currently there are 56 active IPOs in the pipeline as of June 2, 2016. No SPACs or Unit Offerings are included. NEW FILINGS Company: Vencore Holding Corp. Symbol: VNCR Description: Vencore is a leading provider of mission-critical, innovation-driven services[…]